Alzheimer's Disease Trial, Recruiting NCT06840587 Sponsor: University of North Carolina, Chapel Hill Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06840587
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • You must be able to speak English
  • Your planned discharge destination should be home, assisted living, or long-term care
  • You must have a diagnosis of dementia
  • You must have a caregiver who is willing to take part in the trial

For caregivers:

  • You must be able to speak English
  • You must be the legally authorized representative (someone officially recognized to make decisions on behalf of the patient) and also provide regular support to the person with dementia

For care facilities (SNFs - Skilled Nursing Facilities):

  • The facility must be located within 120 miles of UNC-Chapel Hill
  • The facility must admit at least 75 skilled nursing patients per year

Who may not be able to join:

For patients:

  • You may not be eligible if you already have a planned return to hospital for a procedure or treatment within 30 days of joining the trial

For caregivers:

  • You may not be eligible if your role as legal representative was assigned by a court (for example, a court-appointed guardian)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

The information above is based only on the official criteria listed for this trial. Every situation is different, and only the trial team can confirm whether you or your loved one may be eligible.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mark Toles, PhD, RN, University of North Carolina, Chapel Hill

Phone: 9198438874

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 April 2025
Est. completion
30 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Caregiver Strain; Patient Neuropsychiatric Symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov